TREAT-NMD workshop: Pattern recognition in genetic muscle diseases using muscle MRI. 25-26 February 2011, Rome, Italy

Neuromuscular Disorders

Volumn 22, Issue SUPPL. 2, 2012, Pages

  Straub, Volker ^a   Carlier, Pierre G ^b   Mercuri, Eugenio ^c  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 6; DESMIN; DYNAMIN II; FILAMIN; FILAMIN C; MUSCLE PROTEIN; MYOTILIN PROTEIN; PROTEIN ZASP; RYANODINE RECEPTOR 1; UNCLASSIFIED DRUG;

ACTA1 GENE; ANO5 GENE; ARTICLE; CENTRONUCLEAR MYOPATHY; DESMIN GENE; DIAGNOSTIC IMAGING; DYNAMIN 2 GENE; FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY; GENE MUTATION; GENETIC ASSOCIATION; GLYCOGEN STORAGE DISEASE TYPE 2; HUMAN; LAMINOPATHY; LIMB GIRDLE MUSCULAR DYSTROPHY; LIMB GIRDLE MUSCULAR DYSTROPHY 2A; LIMB GIRDLE MUSCULAR DYSTROPHY 2I; LIMB GIRDLE MUSCULAR DYSTROPHY 2J; LIMB GIRDLE MUSCULAR DYSTROPHY 2L; MIYOSHI MYOPATHY; MUSCLE DISEASE; MUTATOR GENE; MYOTONIC DYSTROPHY; NEB GENE; NEMALINE MYOPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RECEPTOR GENE; RYANODINE RECEPTOR 1 GENE; SARCOGLYCANOPATHY; SEPN1 GENE; SGCA GENE; WORKSHOP;

HUMANS; MAGNETIC RESONANCE IMAGING; MUSCLE PROTEINS; MUSCLES; MUSCULAR DISEASES; ROME;

EID: 84866306180     PISSN: 09608966     EISSN: 18732364     Source Type: Journal    
DOI: 10.1016/j.nmd.2012.08.002     Document Type: Article

References (46)

1. Mercuri E., Jungbluth H., Muntoni F. Muscle imaging in clinical practice. diagnostic value of muscle magnetic resonance imaging in inherited neuromuscular disorders. Curr Opin Neurol 2005, 18:526-537.
2. Jungbluth H., Davis M.R., Muller C., et al. Magnetic resonance imaging of muscle in congenital myopathies associated with RYR1 mutations. Neuromuscul Disord 2004, 14:785-790.
3. Jungbluth H., Sewry C.A., Muntoni F. Core myopathies. Semin Pediatr Neurol 2011, 18:239-249.
4. Mercuri E., Pichiecchio A., Allsop J., et al. Muscle MRI in inherited neuromuscular disorders: past, present, and future. J Magn Reson Imaging 2007, 25:433-440.
5. Quijano-Roy S., Carlier R.Y., Fischer D. Muscle imaging in congenital myopathies. Semin Pediatr Neurol 2011, 18:221-229.
6. Mercuri E., Cini C., Pichiecchio A., et al. Muscle magnetic resonance imaging in patients with congenital muscular dystrophy and Ullrich phenotype. Neuromuscul Disord 2003, 13:554-558.
7. Klein A., Lillis S., Munteanu I., et al. Clinical and genetic findings in a large cohort of patients with ryanodine receptor 1 gene-associated myopathies. Hum Mutat 2012, 33:981-988.
8. Klein A., Jungbluth H., Clement E., et al. Muscle magnetic resonance imaging in congenital myopathies due to ryanodine receptor type 1 gene mutations. Arch Neurol 2011, 68:1171-1179.
9. Heckmatt J.Z., Dubowitz V. Ultrasound imaging and directed needle biopsy in the diagnosis of selective involvement in muscle disease. J Child Neurol 1987, 2:205-213.
10. Heckmatt J.Z., Leeman S., Dubowitz V. Ultrasound imaging in the diagnosis of muscle disease. J Pediatr 1982, 101:656-660.
11. Jungbluth H., Lillis S., Zhou H., et al. Late-onset axial myopathy with cores due to a novel heterozygous dominant mutation in the skeletal muscle ryanodine receptor (RYR1) gene. Neuromuscul Disord 2009, 19:344-347.
12. Bevilacqua J.A., Bitoun M., Biancalana V., et al. " Necklace" fibers, a new histological marker of late-onset MTM1-related centronuclear myopathy. Acta Neuropathol 2009, 117:283-291.
13. Wallgren-Pettersson C., Kivisaari L., Jaaskelainen J., et al. Ultrasonography, CT, and MRI of muscles in congenital nemaline myopathy. Pediatr Neurol 1990, 6:20-28.
14. Wallgren-Pettersson C., Lehtokari V.L., Kalimo H., et al. Distal myopathy caused by homozygous missense mutations in the nebulin gene. Brain 2007, 130:1465-1476.
15. Jungbluth H., Sewry C.A., Counsell S., et al. Magnetic resonance imaging of muscle in nemaline myopathy. Neuromuscul Disord 2004, 14:779-784.
16. Azevedo M.F., Barra G.B., Naves L.A., et al. Selenoprotein-related disease in a young girl caused by nonsense mutations in the SBP2 gene. J Clin Endocrinol Metab 2010, 95:4066-4071.
17. Mercuri E., Lampe A., Allsop J., et al. Muscle MRI in Ullrich congenital muscular dystrophy and bethlem myopathy. Neuromuscul Disord 2005, 15:303-310.
18. Mercuri E., Clements E., Offiah A., et al. Muscle magnetic resonance imaging involvement in muscular dystrophies with rigidity of the spine. Ann Neurol 2010, 67:201-208.
19. Romero N.B., Bitoun M. Centronuclear myopathies. Semin Pediatr Neurol 2011, 18:250-256.
20. Jeub M., Bitoun M., Guicheney P., et al. Dynamin 2-related centronuclear myopathy: clinical, histological and genetic aspects of further patients and review of the literature. Clin Neuropathol 2008, 27:430-438.
21. Schessl J., Medne L., Hu Y., et al. MRI in DNM2-related centronuclear myopathy: evidence for highly selective muscle involvement. Neuromuscul Disord 2007, 17:28-32.
22. Susman R.D., Quijano-Roy S., Yang N., et al. Expanding the clinical, pathological and MRI phenotype of DNM2-related centronuclear myopathy. Neuromuscul Disord 2010, 20:229-237.
23. Jungbluth H., Zhou H., Sewry C.A., et al. Centronuclear myopathy due to a de novo dominant mutation in the skeletal muscle ryanodine receptor (RYR1) gene. Neuromuscul Disord 2007, 17:338-345.
24. Bohm J., Yis U., Ortac R., et al. Case report of intrafamilial variability in autosomal recessive centronuclear myopathy associated to a novel BIN1 stop mutation. Orphanet J Rare Dis 2010, 5:35.
25. Carboni N., Mura M., Marrosu G., et al. Muscle imaging analogies in a cohort of patients with different clinical phenotypes caused by LMNA gene mutations. Muscle Nerve 2010, 41:458-463.
26. Pichiecchio A., Uggetti C., Ravaglia S., et al. Muscle MRI in adult-onset acid maltase deficiency. Neuromuscul Disord 2004, 14:51-55.
27. Carlier R.Y., Laforet P., Wary C., et al. Whole-body muscle MRI in 20 patients suffering from late onset pompe disease: involvement patterns. Neuromuscul Disord 2011, 21:791-799.
28. Fischer D., Walter M.C., Kesper K., et al. Diagnostic value of muscle MRI in differentiating LGMD2I from other LGMDs. J Neurol 2005, 252:538-547.
29. Mercuri E., Bushby K., Ricci E., et al. Muscle MRI findings in patients with limb girdle muscular dystrophy with calpain 3 deficiency (LGMD2A) and early contractures. Neuromuscul Disord 2005, 15:164-171.
30. Wattjes M.P., Kley R.A., Fischer D. Neuromuscular imaging in inherited muscle diseases. Eur Radiol 2010, 20:2447-2460.
31. Matsubara E., Tsuchiya A., Minami N., et al. A unique case of limb-girdle muscular dystrophy type 2A carrying novel compound heterozygous mutations in the human CAPN3 gene. Eur J Neurol 2007, 14:819-822.
32. Paradas C., Llauger J., Diaz-Manera J., et al. Redefining dysferlinopathy phenotypes based on clinical findings and muscle imaging studies. Neurology 2010, 75:316-323.
33. Kesper K., Kornblum C., Reimann J., et al. Pattern of skeletal muscle involvement in primary dysferlinopathies: a whole-body 3.0-T magnetic resonance imaging study. Acta Neurol Scand 2009, 120:111-118.
34. Bolduc V., Marlow G., Boycott K.M., et al. Recessive mutations in the putative calcium-activated chloride channel anoctamin 5 cause proximal LGMD2L and distal MMD3 muscular dystrophies. Am J Hum Genet 2010, 86:213-221.
35. Hicks D., Sarkozy A., Muelas N., et al. A founder mutation in anoctamin 5 is a major cause of limb-girdle muscular dystrophy. Brain 2011, 134:171-182.
36. Udd B., Vihola A., Sarparanta J., Richard I., Hackman P. Titinopathies and extension of the M-line mutation phenotype beyond distal myopathy and LGMD2J. Neurology 2005, 64:636-642.
37. Fischer D., Kley R.A., Strach K., et al. Distinct muscle imaging patterns in myofibrillar myopathies. Neurology 2008, 71:758-765.
38. Olive M., Odgerel Z., Martinez A., et al. Clinical and myopathological evaluation of early- and late-onset subtypes of myofibrillar myopathy. Neuromuscul Disord 2011, 21:533-542.
39. Schramm N., Born C., Weckbach S., et al. Involvement patterns in myotilinopathy and desminopathy detected by a novel neuromuscular whole-body MRI protocol. Eur Radiol 2008, 18:2922-2936.
40. Walter M.C., Reilich P., Huebner A., et al. Scapuloperoneal syndrome type kaeser and a wide phenotypic spectrum of adult-onset, dominant myopathies are associated with the desmin mutation R350P. Brain 2007, 130:1485-1496.
41. Kley R.A., Hellenbroich Y., van der Ven P.F., et al. Clinical and morphological phenotype of the filamin myopathy: a study of 31 German patients. Brain 2007, 130:3250-3264.
42. Reilich P., Krause S., Schramm N., et al. A novel mutation in the myotilin gene (MYOT) causes a severe form of limb girdle muscular dystrophy 1A (LGMD1A). J Neurol 2011, 258:1437-1444.
43. Palmio J., Sandell S., Suominen T., et al. Distinct distal myopathy phenotype caused by VCP gene mutation in a finnish family. Neuromuscul Disord 2011, 21:551-555.
44. Olsen D.B., Gideon P., Jeppesen T.D., Vissing J. Leg muscle involvement in facioscapulohumeral muscular dystrophy assessed by MRI. J Neurol 2006, 253:1437-1441.
45. Kan H.E., Scheenen T.W., Wohlgemuth M., et al. Quantitative MR imaging of individual muscle involvement in facioscapulohumeral muscular dystrophy. Neuromuscul Disord 2009, 19:357-362.
46. Tasca G., Pescatori M., Monforte M., et al. Different molecular signatures in magnetic resonance imaging-staged facioscapulohumeral muscular dystrophy muscles. PLoS One 2012, 7:e38779.